THQ (abrdn Healthcare Opportunities Fund) director files clean Form 3 with no trades

Rhea-AI Filing Summary

abrdn Healthcare Opportunities Fund director Mahai Chris LaVictoire has filed an initial Form 3, which identifies him as a director of the fund. The filing reports no purchases, sales, gifts, derivative exercises, or other transactions, and shows no derivative positions or holding entries.

Key Terms

Form 3, reportingPersons, derivativeSummary, transactionSummary

4 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reportingPersons regulatory

""reportingPersons": [ { "name": "Mahai Chris LaVictoire" } ]"

derivativeSummary financial

""derivativeSummary": []"

transactionSummary financial

""transactionSummary": { "buyCount": 0, "sellCount": 0 }"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 06/11/2026 - 11:31 AM Accepted by SEC EDGAR 06/11/2026 - 11:31 AM Learn about SEC filing dates

FAQ

What does the THQ Form 3 filing for Mahai Chris LaVictoire show?

The Form 3 identifies Mahai Chris LaVictoire as a director of abrdn Healthcare Opportunities Fund. It reports no transactions, no derivative positions, and no holding entries in this initial insider ownership statement.

Did Mahai Chris LaVictoire buy or sell THQ shares in this Form 3?

No transactions are reported for Mahai Chris LaVictoire in this Form 3. The transaction summary shows zero buys, zero sells, zero derivative exercises, and no gifts or tax-withholding dispositions.

Are there any derivative securities reported for THQ in this Form 3?

No derivative securities are listed in this Form 3. The derivative summary is empty and the transaction summary shows zero derivative transactions and zero derivative exercise shares for the reporting person.

What insider role does Mahai Chris LaVictoire have at abrdn Healthcare Opportunities Fund (THQ)?

Mahai Chris LaVictoire is reported as a director of abrdn Healthcare Opportunities Fund. The Form 3 flags him as a director, with no officer role and not a ten percent owner in this filing.

Does the THQ Form 3 include any holding entries for Mahai Chris LaVictoire?

The Form 3 transaction summary shows zero holding entries for Mahai Chris LaVictoire. It is a baseline insider identification filing without reported common stock holdings or derivative positions in the provided data.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mahai Chris LaVictoire

(Last) (First) (Middle)

C/O ABRDN

1900 MARKET STREET, SUITE 200

(Street)

PHILADELPHIA PENNSYLVANIA 19103

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/09/2026

3. Issuer Name and Ticker or Trading Symbol
abrdn Healthcare Opportunities Fund [ THQ ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Robert Stieger by POA from Reporting Person	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)